The Carcinogen Identification Committee is a group of expert scientists appointed by the Governor to identify chemicals that have been clearly shown through scientifically valid testing according to generally accepted principles to cause cancer.
December 10, 1998 Meeting of the Science Advisory Board's Carcinogen Identification Committee (CIC). Consideration for listing of MTBE, 2-Aminofluorene, and 4-Amino-2-nitrophenol
Committee meetings are usually held at the CalEPA headquarters building at 1001 I Street in Sacramento, California. Learn what to expect when you attend a meeting.
December 9, 1998 Meeting of the Science Advisory Board's Developmental and Reproductive Toxicant (DART) Identification Committee. Consideration for listing MTBE
Request for information, chemicals under consideration for possible listing via the Authoritative Bodies mechanisms: Avermectin B1, delta-8,9-isomer of avermectin B1, nitrapyrin, thiabendazole, triadimefon, triphenyltin hydroxide.
